Seeking Alpha

Canadian medical-technology company Nordion (NDZ +0.8%) gains after its FQ3 swung to a profit on...

Canadian medical-technology company Nordion (NDZ +0.8%) gains after its FQ3 swung to a profit on fewer one-time expenses and higher sales. The quarter marks a reversal as sales have slipped in recent quarters, due in part to supply interruptions and the temporary shutdown of a reactor. In its targeted-therapies segment, revenue grew 15%, while gross margins widened to 54.7% from 52.7%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs